Intravascular brachytherapy using 90Sr for saphenous vein grafts having diameters ranging from 2.0-5.0 mm

Brachytherapy

Volumn 3, Issue 3, 2004, Pages 173-178

  Mignano, John E ^a   Rivard, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

AAPM TG 43; Brachytherapy dosimetry; Intravascular brachytherapy; Saphenous vein grafts

Indexed keywords

STRONTIUM 90; STRONTIUM;

ANALYTICAL ERROR; ARTICLE; BLOOD VESSEL DIAMETER; BRACHYTHERAPY; CATHETER; COMPARATIVE STUDY; CORONARY ARTERY; DEVICE; DOSIMETRY; INTRAVASCULAR BRACHYTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; CATHETERIZATION; GRAFT OCCLUSION; HISTOLOGY; INSTRUMENTATION; METHODOLOGY; SAPHENOUS VEIN; TRANSPLANTATION;

BRACHYTHERAPY; CATHETERIZATION; GRAFT OCCLUSION, VASCULAR; SAPHENOUS VEIN; STRONTIUM RADIOISOTOPES;

EID: 1142292138     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2004.05.004     Document Type: Article

References (16)

1. C. Bauter, E. Hubert, and A. Prat Predictors of restenosis after coronary artery stent implantation J Amer Coll Cardiol 31 1998 1291 1298
2. S. Apisarnthanarax, and P. Chougule Intravascular brachytherapy, a review of the current vascular biology Am J Clin Oncol 26 2003 e13 e21
3. D.-H. Cha, A. Ajani, and E. Cheneau Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis J Invas Cardiol 14 2002 432 437
4. V. Coen, P. Serruys, and W. Sauerwein RENO, A European postmarket surveillance registry confirms effectiveness of coronary brachytherapy in routine clinical practice Int J Radiat Oncol Biol Phys 55 2003 1019 1026
5. P.M. Devlin The future of coronary artery radiation therapy - "The CART before the (unbridled) horse!" Brachytherapy 2 2003 73 74
6. P. Tripuraneni The future of CART in the era of drug eluting stents: "It's not over until it's over." Brachytherapy 2 2003 74 76
7. M. Castagna, G. Mintz, and R. Waksman Comparative efficacy of γ-irradiation for treatment of in-stent restenosis in saphenous vein graft versus native coronary artery in-stent restenosis Circulation 104 2001 3020 3022
8. 90Sr for saphenous vein grafts having diameters ranging from 2.0-5.0 mm Brachytherapy 2 2003 44 45 (abstract)
9. 90Sr for extended radial ranges Med Phys 30 2003 1465 1466 (abstract)
10. C.G. Soares Consistency standards for source strength of beta-particle sources Vascular Radiotherapy Monitor 3 2001 59 63
11. R. Nath, L. Anderson, and G. Luxton Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 Med Phys 22 1995 209 236
12. M.J. Rivard, B.M. Coursey, and L.A. DeWerd Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations Med Phys 31 2004 633 674
13. R. Nath, H. Amols, and C. Coffey Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60 Med Phys 26 1999 119 147
14. Bureau of Radiologic Health Radiological health handbook 1970 US Department of Health, Education, and Welfare Rockville, MD p. 122
15. M.J. Rivard, H.D. Zinkin, and J.E. Mignano Treatment of in-stent restenosis for saphenous vein grafts using intravascular brachytherapy: Regulatory challenges and clinical application J Invas Cardiol 16 2004 96 99
16. M. Suntharalingam, W.K. Laskey, and W. Tantibhedhyangkui Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: Angiographic and clinical outcomes Int J Radiat Oncol Biol Phys 57 2003 536 542